Medical device company PainChek (ASX: PCK), developer of a smartphone-based pain assessment and monitoring application, has been granted a patent in 20 European nations by the European Patent Office (EPO). The patent application is titled “A Pain Assessment Method and System” and allows PainChek to safeguard the intellectual property of its pain assessment and monitoring
Read More
COVID-19 was a turning point for the telehealth industry. In Australia, between 2020 and 2022, more than 100 million telehealth services were delivered to around 17 million Australians. Over $5 billion in Medicare benefits were paid, and about 90,000 medical practitioners have now used telehealth services to support their patients. Aussies have been quick to
Read More
The XJO is expected to open flat this morning. The U.S recovered overnight and their futures are flat this morning. We recovered well yesterday, rebounding off the underlying uptrend line, key support at 7,700, and the 50 Day MA. We stalled at 7,800 though, and this morning we will test it again. Markets are likely
Read More
According to TechSci Research report, “Hypersonic Weapons Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Hypersonic Weapons Market stood at USD 8.41 billion in 2022 and is anticipated to grow with a CAGR of 8.23% in the forecast period, 2024-2028 The Global Hypersonic Weapons Market represents a dynamic and strategically significant
Read More
Ischaemia is a condition in which the blood supply to any part of the body is so severely restricted that it receives no oxygen and can result in a stroke. Early detection is crucial, and so, medical devices company EMVision (ASX: EMV) has been conducting multi-site clinical trials to advance its neurodiagnostic AI algorithms to
Read More
Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection Kit for the US market due to increased competition and changing market dynamics. It will now focus its effort and investment on the anticipated launch of the EasyScreen Gastrointestinal Parasite Detection Kit in the US.
Read More